Trial Profile
Retrospective Study Comparing Clinical Outcomes and Utilization of Belatacept and Tacrolimus based immunosuppression in Adult Patients With a Transplanted Kidney.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 06 Oct 2016 New trial record